Dr. Alison Bertuch, MD, PhD, is an Associate Professor in Pediatrics, Hematology/Oncology, and Molecular and Human Genetics at Baylor College of Medicine (BCM). She received her BS from the Massachusetts Institute of Technology, and her MD and PhD from the University of Rochester. Subsequently, she received her training in Pediatrics and Pediatric Hematology/Oncology at BCM.
Dr. Bertuch is the Director of the Bone Failure Program at Texas Children’s Hospital and is an internationally recognized leader in the fields of telomere biology and bone marrow failure, impacting both basic and translational fields of study. Her research has been funded by the National Institute of General Medical Sciences, the National Heart, Lung, and Blood Institute, Cancer Prevention and Research Institute of Texas, American Society of Hematology and Hyundai Hope on Wheels, and has been published in a variety of journals including Blood, Cell Reports, Clinical Genetics, Human Mutation, Nature Structural and Molecular Biology, Pediatric Blood & Cancer, and Scientific Reports. She has been elected to the Society for Pediatric Research and the American Society for Clinical Investigation.
She is the current Chairperson of the NIH Molecular Genetics B study section. She was Co-Chair of the 9th International Congress on Shwachman-Diamond Syndrome and Vice-Chair and Chair of the American Society of Hematology Scientific Committee on Bone Marrow Failure in 2018 and 2019, respectively. She served as an inaugural Executive Committee Member of the North American Pediatric Aplastic Anemia Consortium from 2013-2016, and continues on as a member of the Steering Committee. She is on the Scientific Advisory Board of the Shwachman-Diamond Syndrome Registry and on the Medical Advisory Board member for the Team Telomere, a worldwide community for families affected by dyskeratosis congenita and related telomere biology disorders.